Shares of Henry Schein Inc. HSIC slipped 4.09% to $69.94 Wednesday, on what proved to be an all-around mixed trading session ...

The stock's rise snapped a three-day losing streak.

Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ ...

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports.

The firm purchased 501,734 shares of the company’s stock, valued at approximately $34,720,000. Raymond James Financial Inc. owned about 0.40% of Henry Schein as of its most recent filing with ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

HENRY SCHEIN ($HSIC) posted quarterly earnings results on Tuesday, February 25th. The company reported earnings of $1.19 per share, missing estimates of $1.24 by $0. ...

Investors and stakeholders in Henry Schein Inc. will likely watch for further announcements to understand the implications of this executive shift. The company’s stock performance and market ...

HENRY SCHEIN ($HSIC) is expected to release its quarterly earnings data on Tuesday, February 25th before market open, per Finnhub. Analysts are expecting revenue of ...